MSCs or Mesenchymal stem cells are derived from the stromal vascular fraction (SVF) or stromal cells. SVF is obtained from liposuction of excess adipose or fat tissue from a person’s body. This specific type of stem cells is multipotent.

In other words, mesenchymal stem cells can turn into other cell types. This quality of MSCs opens great possibilities. MSCs are also easier to obtain than other stem cell types since they have to be harvested from the person’s own body.

Research continues to discover increasing body of evidence demonstrating the potential of Mesenchymal stem cells in relieving symptoms of autoimmune diseases, such as multiple sclerosis and rheumatoid arthritis.

Studies with MSCs have shown the Mesenchymal stemcells’ ability to reduce the adverse effects of some inflammatory conditions by controlling immune response. MSCs aid regulation of the immune system and tissue repair. This is achieved with a specific type of cell-to-cell communication, also called paracrine signaling. MSCs have shown positive outcomes in the management of autoimmune disorders, such as multiple sclerosis and rheumatoid arthritis.

Multiple Sclerosis

MS or Multiple Sclerosis is a chronic autoimmune disease affecting the central nervous system. MS causes the immune system to attack the myelin sheath (protective coating) that covers the axon (the longer part of neurons which connects to other neurons). As a result, lesions form and prevent communication between neurons. This results in impaired brain function.

Human Adipose-Derived Mesenchymal Stem Cells infusions have shown toconsiderably reduce the severity of the condition. It is believed that mesenchymal stem cells are able to modify the immune response from inflammatory to anti-inflammatory, speeding recovery.

This ability of mesenchymal stem cells to aid repair of the myelin sheath in neurons, accompanied by reduced inflammation can prove a great leap in the treatment of MS.

Rheumatoid Arthritis

RA or Rheumatoid Arthritis is a chronic condition that results in which inflammation leads to tissue damage in the joints. T cells, that play a major role in immune response, are the major effector in RA.

Mesenchymal stem cells have shown to change the behavior of T cells, and improve recovery.

In addition, mesenchymal stem cells can differentiate into different types of cells. This can aid direct tissue repair.

If mesenchymal stem cells can reduce inflammation, modify the behavior of T cells, and help in direct tissue repair, their use in treatment of disorders, such as MS and RA, can prove to be a great leap in the treatment of autoimmune diseases.

If you are looking for fat derived stem cell therapy or stromal vascular fraction, call the leading stem cell treatment center in Chicago, The Regenerative Stem Cell Institute at 855-340-7836 today!